Lipofectin‐aided cell delivery of ribozyme targeted to human urokinase receptor mRNA
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
A 37‐mer hammerhead ribozyme has been designed to efficiently cleave the 1.4 kb mRNA of the urokinase plasminogen activator receptor (uPAR). Under in vitro conditions, the chemically synthesized ribozyme cleaved uPAR mRNA and inhibited its translation in a concentration‐dependent fashion. The ribozymes were 5′‐[35 S]thiophosphorylated and used as a model to analyze conditions for RNA delivery in a cultured human osteosarcoma cell system. Ribozymes degraded immediately in cell‐conditioned medium but ribozymes complexed with lipofectin were protected from RNases for up to 22 h. Lipofectin rapidly transported ribozyme into the cell, where it accumulated almost exclusively in the cytoplasm. Thus, lipofectin dramatically enhances stability and cytoplasmic delivery of ribozymes, potentially enabling targeting of mRNA in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cationic liposome-mediated RNA transfection.
Malone, R. W., Felgner, P. L., & Verma, I. M. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.16.6077 · Cited by 911
Cited by
On the mechanism whereby cationic lipids promote intracellular delivery of polynucleic acids
Hafez, I., Maurer, N., & Cullis, P. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301506 · Cited by 601
Mahmood, N., Mihalcioiu, C., & Rabbani, S. A. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00024 · Cited by 478
“A specific ribozyme targeting uPAR mRNA has been used to disrupt uPAR translation in human osteosarcoma cells in vitro (244).”
MethodSu, S.-C., Lin, C.-W., Yang, W.-E., Fan, W.-L., & Yang, S.-F. (2016) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2016.1113260 · Cited by 145
“has been used to cleave the mRNA of uPAR and to inhibit the protein translation.[114] Furthermore, RNAi technology has been used extensively as a favorable”
MethodKarikó, K., Kuo, A., & Barnathan, E. S. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300930 · Cited by 89
Self-citationIn vivo protein expression from mRNA delivered into adult rat brain
Karikó, K., Keller, J. M., Harris, V. A., Langer, D. J., & Welsh, F. A. (2001) · Journal of Neuroscience Methods · doi:10.1016/s0165-0270(00)00355-1 · Cited by 24
Self-citation
Metadata
- Authors
- Karikó, K., Megyeri, K., Xiao, Q., & Barnathan, E. S.
- Venue
- FEBS Letters
- Publisher
- Wiley
- Published
- 1994-09-19
- Volume
- 352
- Issue
- 1
- Pages
- 41-44
- ISSN
- 0014-5793 (ISSN-L)
- 1873-3468
- OpenAlex
- W2039705756
- Cited by
- 35
- References
- 1
- FWCI
- 1.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Lipofectin‐aided cell delivery of ribozyme targeted to human urokinase receptor mRNA. https://app.cochat.ai/papers/10.1016/0014-5793(94)00914-7
- The paper
- Karikó, K., Megyeri, K., Xiao, Q., & Barnathan, E. S. (1994). Lipofectin‐aided cell delivery of ribozyme targeted to human urokinase receptor mRNA. FEBS Letters. https://doi.org/10.1016/0014-5793(94)00914-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.